The briefing
New findings indicate that certain B‑cell profiles could help identify cancer patients at higher risk of developing colitis during immunotherapy. If validated, the approach may guide monitoring and management of treatment side effects.
Original headline
B Cells Could Predict Colitis Risk in Immunotherapy